Johnson & Johnson (NYSE:JNJ) stock and Halozyme (HALO) stock were downgraded at Leerink Partners on earlier than expected price controls for products. Read more here.

Once again, AbbVie dominates doctors’ ranking of makers of immunology meds. | Just like last year, the Skyrizi and Rinvoq ...

On Sunday, U.S. President Donald Trump changed that precedent, announcing that he would sign an executive order Monday to ...

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at ...

Johnson & Johnson (JNJ) posts promising late-stage trial data for plaque psoriasis icotrokinra developed with Protagonist ...

In a high-stakes trial underway in the U.S. District Court for the Central District of California, Innovative Health CEO Rick ...

Virginia localities are preparing to move into phase 1C as more vaccines become available to more of the population. One of ...

Johnson & Johnson took a shot at the Trump administration’s tariff policy and outlined its plans for how it will absorb the negative impact. But even with the extra costs, which the medical ...

House Speaker Mike Johnson said he doesn't use Signal, an encrypted messaging app. "A lot of them text," Johnson said of his GOP colleagues. "That's our main means of communication." He jokes that ...

(RTTNews) - Johnson & Johnson (JNJ) announced the FDA has approved IMAAVY, a human FcRn-blocking monoclonal antibody, for the treatment of generalized myasthenia gravis. The approval is supported ...

Speaker Mike Johnson (R-La.) said he believes the House can pass President Trump’s tax agenda by Memorial Day. Speaking with reporters on Monday, Johnson said he met with Treasury Secretary ...